| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| G0463 |
Hospital outpatient clinic visit for assessment and management of a patient |
385,039 |
315,869 |
$28.57M |
| J2350 |
Injection, ocrelizumab, 1 mg |
715 |
638 |
$8.71M |
| 96361 |
Intravenous infusion, hydration; each additional hour |
19,886 |
15,762 |
$5.54M |
| 77386 |
|
8,350 |
731 |
$3.81M |
| 99283 |
Emergency department visit for the evaluation and management, moderate severity |
29,886 |
26,265 |
$2.85M |
| 99285 |
Emergency department visit for the evaluation and management, high severity with immediate threat to life |
38,971 |
34,869 |
$2.72M |
| 96365 |
Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour |
21,697 |
15,324 |
$2.55M |
| 99284 |
Emergency department visit for the evaluation and management, high severity |
33,296 |
29,847 |
$2.39M |
| 93306 |
Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete |
10,837 |
10,427 |
$2.21M |
| 74177 |
Computed tomography, abdomen and pelvis; with contrast material |
14,574 |
13,808 |
$2.13M |
| J1569 |
Injection, immune globulin, (gammagard liquid), non-lyophilized, (e.g., liquid), 500 mg |
1,894 |
599 |
$2.09M |
| J1745 |
Injection, infliximab, excludes biosimilar, 10 mg |
1,623 |
1,539 |
$2.06M |
| 93451 |
|
2,038 |
1,824 |
$2.02M |
| J2357 |
Injection, omalizumab, 5 mg |
2,492 |
1,949 |
$1.86M |
| J3380 |
Injection, vedolizumab, intravenous, 1 mg |
1,027 |
942 |
$1.81M |
| J2323 |
Injection, natalizumab, 1 mg |
1,263 |
1,138 |
$1.76M |
| 70553 |
Magnetic resonance imaging, brain; without contrast material, followed by contrast material and further sequences |
7,882 |
7,668 |
$1.70M |
| U0003 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r |
24,000 |
20,262 |
$1.61M |
| 59025 |
Fetal non-stress test |
8,845 |
4,621 |
$1.33M |
| J0585 |
Injection, onabotulinumtoxina, 1 unit |
6,634 |
5,847 |
$1.33M |
| 96366 |
Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour |
5,828 |
4,282 |
$1.32M |
| 45380 |
Colonoscopy, flexible; with biopsy, single or multiple |
3,535 |
3,438 |
$1.28M |
| 43239 |
Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple |
3,809 |
3,704 |
$1.26M |
| 70450 |
Computed tomography, head or brain; without contrast material |
9,753 |
9,066 |
$1.18M |
| 97110 |
Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion |
48,919 |
27,032 |
$1.16M |
| 96415 |
|
4,088 |
3,418 |
$1.08M |
| Q3014 |
Telehealth originating site facility fee |
50,315 |
44,091 |
$1.01M |
| 31579 |
|
3,194 |
3,053 |
$841K |
| 96413 |
Chemotherapy administration, intravenous infusion; up to 1 hour, single or initial substance |
9,931 |
7,305 |
$836K |
| 71275 |
Computed tomographic angiography, chest, with contrast material |
5,609 |
5,323 |
$762K |
| 52000 |
|
1,516 |
1,469 |
$752K |
| 96360 |
Intravenous infusion, hydration; initial, 31 minutes to 1 hour |
9,022 |
6,243 |
$743K |
| J9271 |
Injection, pembrolizumab, 1 mg |
183 |
128 |
$740K |
| 93303 |
Transthoracic echocardiography for congenital cardiac anomalies, follow-up or limited study |
3,142 |
3,003 |
$733K |
| 11042 |
Debridement, subcutaneous tissue (includes epidermis, dermis, and subcutaneous tissue); first 20 sq cm |
4,688 |
2,282 |
$686K |
| 64615 |
|
2,878 |
2,781 |
$657K |
| 76705 |
Ultrasound, abdominal, real time with image documentation; limited |
9,741 |
9,261 |
$638K |
| 76830 |
Ultrasound, transvaginal |
7,467 |
7,195 |
$601K |
| 45385 |
Colonoscopy, flexible; with removal of tumor(s), polyp(s), or other lesion(s) |
1,675 |
1,618 |
$550K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
17,584 |
15,047 |
$542K |
| 99281 |
Emergency department visit for the evaluation and management, self-limited or minor |
5,219 |
4,332 |
$537K |
| 99282 |
Emergency department visit for the evaluation and management, low to moderate severity |
6,153 |
5,384 |
$531K |
| 80307 |
Drug test(s), presumptive, any number of drug classes; immunoassay |
16,617 |
14,664 |
$500K |
| J2182 |
Injection, mepolizumab, 1 mg |
419 |
388 |
$493K |
| 80053 |
Comprehensive metabolic panel |
122,907 |
103,528 |
$488K |
| 74183 |
|
2,815 |
2,681 |
$484K |
| Q5103 |
Injection, infliximab-dyyb, biosimilar, (inflectra), 10 mg |
525 |
476 |
$474K |
| 74176 |
Computed tomography, abdomen and pelvis; without contrast material |
3,389 |
3,224 |
$447K |
| 20610 |
|
2,959 |
2,670 |
$420K |
| 31231 |
|
2,619 |
2,538 |
$415K |
| 96130 |
|
681 |
662 |
$412K |
| 97140 |
Manual therapy techniques, each 15 minutes (e.g., mobilization/manipulation, manual lymphatic drainage) |
22,861 |
12,468 |
$406K |
| 20611 |
|
2,078 |
1,832 |
$396K |
| 78452 |
Myocardial perfusion imaging, tomographic (SPECT); multiple studies at rest and/or stress |
1,483 |
1,407 |
$394K |
| 76856 |
Ultrasound, pelvic (nonobstetric), real time with image documentation; complete |
7,074 |
6,851 |
$380K |
| 11102 |
|
1,589 |
1,510 |
$373K |
| 97530 |
Therapeutic activities, direct patient contact, each 15 minutes |
15,685 |
9,916 |
$361K |
| 73721 |
Magnetic resonance imaging, any joint of lower extremity; without contrast material |
2,401 |
2,274 |
$359K |
| 76816 |
Ultrasound, pregnant uterus, real time with image documentation, follow-up |
6,971 |
6,046 |
$342K |
| C9803 |
Hospital outpatient clinic visit specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source |
13,201 |
12,416 |
$332K |
| 78815 |
Positron emission tomography (PET) for limited area imaging |
711 |
697 |
$312K |
| 20553 |
|
2,163 |
1,637 |
$306K |
| 72148 |
Magnetic resonance imaging, lumbar spine; without contrast material |
2,582 |
2,534 |
$293K |
| 70551 |
Magnetic resonance imaging, brain; without contrast material |
2,152 |
2,103 |
$293K |
| C8929 |
Transthoracic echocardiography with contrast, or without contrast followed by with contrast, real-time with image documentation (2d), includes m-mode recording, when performed, complete, with spectral doppler echocardiography, and with color flow doppler echocardiography |
1,602 |
1,521 |
$292K |
| 70496 |
|
1,891 |
1,824 |
$280K |
| 91010 |
|
921 |
899 |
$277K |
| 74160 |
|
2,074 |
2,007 |
$274K |
| 43235 |
|
829 |
802 |
$273K |
| 71250 |
|
5,649 |
5,371 |
$261K |
| 11104 |
|
935 |
892 |
$259K |
| 93308 |
|
1,389 |
1,301 |
$257K |
| 93970 |
|
3,114 |
2,981 |
$248K |
| 80048 |
Basic metabolic panel (calcium, ionized) |
60,476 |
45,757 |
$248K |
| 97112 |
Therapeutic procedure, each 15 minutes; neuromuscular reeducation of movement, balance, coordination |
9,796 |
6,540 |
$243K |
| 11900 |
|
1,335 |
1,261 |
$239K |
| 77334 |
|
2,104 |
1,428 |
$237K |
| 90471 |
Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine |
12,703 |
12,406 |
$234K |
| 77470 |
|
400 |
382 |
$227K |
| 93975 |
|
4,879 |
4,560 |
$221K |
| 76770 |
|
2,943 |
2,842 |
$221K |
| 93017 |
|
3,339 |
3,194 |
$218K |
| 94618 |
|
3,448 |
3,313 |
$217K |
| 97162 |
|
6,167 |
5,964 |
$217K |
| G0378 |
Hospital observation service, per hour |
7,312 |
6,784 |
$216K |
| 97161 |
|
5,380 |
5,223 |
$211K |
| 76536 |
|
2,793 |
2,721 |
$206K |
| 93971 |
|
2,678 |
2,561 |
$205K |
| 11100 |
|
674 |
655 |
$205K |
| 72141 |
|
1,808 |
1,772 |
$204K |
| 70491 |
|
1,923 |
1,835 |
$198K |
| 76942 |
|
4,115 |
3,568 |
$195K |
| 76801 |
|
3,683 |
3,430 |
$195K |
| 74174 |
|
1,760 |
1,684 |
$192K |
| 77336 |
|
3,337 |
1,674 |
$191K |
| 77063 |
Screening digital breast tomosynthesis, bilateral |
4,716 |
4,653 |
$190K |
| 96910 |
|
3,858 |
654 |
$188K |
| P9040 |
Red blood cells, leukocytes reduced, irradiated, each unit |
890 |
710 |
$188K |
| 72197 |
|
1,203 |
1,168 |
$183K |
| 92557 |
|
3,711 |
3,608 |
$181K |
| 31237 |
|
229 |
216 |
$180K |
| 77412 |
|
466 |
74 |
$177K |
| 17110 |
|
1,244 |
1,172 |
$175K |
| J9035 |
Injection, bevacizumab, 10 mg |
139 |
81 |
$170K |
| 76700 |
Ultrasound, abdominal, real time with image documentation; complete |
1,959 |
1,888 |
$167K |
| 76805 |
Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation |
2,547 |
2,497 |
$166K |
| 27447 |
|
46 |
46 |
$158K |
| 70486 |
|
2,568 |
2,499 |
$157K |
| 49083 |
|
506 |
288 |
$152K |
| 36415 |
Collection of venous blood by venipuncture |
188,435 |
151,083 |
$150K |
| 97165 |
|
3,943 |
3,815 |
$147K |
| 77290 |
|
575 |
504 |
$146K |
| 64616 |
|
582 |
514 |
$143K |
| 97802 |
|
3,252 |
3,156 |
$139K |
| 81420 |
Fetal chromosomal aneuploidy genomic sequence analysis panel |
1,453 |
1,419 |
$138K |
| 93978 |
|
2,890 |
2,736 |
$138K |
| 76882 |
|
1,980 |
1,832 |
$136K |
| 30140 |
|
96 |
94 |
$136K |
| 97129 |
|
978 |
668 |
$132K |
| 31575 |
|
760 |
739 |
$127K |
| 87591 |
Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe |
12,554 |
11,685 |
$124K |
| 93325 |
|
5,165 |
4,911 |
$124K |
| 71260 |
Computed tomography, thorax, diagnostic; with contrast material |
5,039 |
4,868 |
$124K |
| 97163 |
|
3,179 |
3,093 |
$124K |
| 76815 |
Ultrasound, pregnant uterus, real time with image documentation, limited |
2,499 |
2,064 |
$123K |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
132,130 |
105,655 |
$123K |
| 76937 |
|
2,894 |
2,517 |
$121K |
| 76811 |
Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation, detailed |
2,412 |
2,327 |
$120K |
| 90651 |
|
1,472 |
1,458 |
$118K |
| G0008 |
Administration of influenza virus vaccine |
10,418 |
10,254 |
$113K |
| 97803 |
|
4,462 |
4,099 |
$112K |
| J0475 |
Injection, baclofen, 10 mg |
685 |
604 |
$112K |
| 17000 |
|
1,165 |
1,085 |
$112K |
| Q5115 |
Injection, rituximab-abbs, biosimilar, (truxima), 10 mg |
42 |
27 |
$112K |
| 71046 |
Radiologic examination, chest; 2 views |
19,612 |
18,113 |
$110K |
| 27130 |
|
24 |
24 |
$109K |
| 96152 |
|
1,165 |
902 |
$108K |
| 97763 |
|
1,096 |
844 |
$105K |
| 90837 |
Psychotherapy, 53 minutes with patient |
1,760 |
902 |
$104K |
| 83880 |
|
15,237 |
13,281 |
$103K |
| 77080 |
|
2,190 |
2,131 |
$103K |
| 73221 |
|
716 |
692 |
$102K |
| 36247 |
|
157 |
118 |
$102K |
| 91034 |
|
330 |
323 |
$102K |
| 93505 |
|
1,001 |
818 |
$101K |
| 88305 |
Level IV - Surgical pathology, gross and microscopic examination |
31,109 |
21,191 |
$99K |
| 64643 |
|
452 |
440 |
$97K |
| 77300 |
|
1,287 |
1,121 |
$93K |
| 93321 |
|
1,610 |
1,526 |
$90K |
| 84443 |
Thyroid stimulating hormone (TSH) |
27,482 |
26,264 |
$88K |
| 93296 |
|
6,810 |
6,686 |
$86K |
| 36561 |
|
83 |
78 |
$84K |
| 92507 |
Treatment of speech, language, voice, communication, and/or auditory processing disorder |
2,319 |
1,533 |
$83K |
| 80197 |
|
19,025 |
11,132 |
$82K |
| 64642 |
|
1,143 |
1,078 |
$82K |
| 76817 |
Ultrasound, pregnant uterus, real time with image documentation, transvaginal |
2,721 |
2,292 |
$82K |
| 92524 |
|
2,143 |
2,053 |
$82K |
| 29581 |
|
757 |
314 |
$81K |
| 76870 |
|
1,084 |
1,047 |
$81K |
| 90715 |
|
4,708 |
4,612 |
$80K |
| 88307 |
|
5,875 |
4,439 |
$80K |
| J2469 |
Injection, palonosetron hcl, 25 mcg |
1,041 |
711 |
$79K |
| 58300 |
|
714 |
690 |
$79K |
| 97535 |
Self-care/home management training, each 15 minutes |
4,663 |
3,571 |
$79K |
| 76642 |
|
1,110 |
951 |
$78K |
| J1756 |
Injection, iron sucrose, 1 mg |
3,996 |
1,860 |
$76K |
| 17311 |
|
206 |
181 |
$75K |
| 84484 |
|
21,607 |
18,376 |
$74K |
| J1561 |
Injection, immune globulin, (gamunex-c/gammaked), non-lyophilized (e.g., liquid), 500 mg |
59 |
39 |
$72K |
| 72156 |
|
1,114 |
1,076 |
$72K |
| 72158 |
|
751 |
723 |
$72K |
| 78830 |
|
267 |
236 |
$71K |
| 93005 |
Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report |
50,645 |
44,067 |
$71K |
| 90472 |
Immunization administration, each additional vaccine (list separately) |
4,090 |
4,023 |
$70K |
| 83970 |
|
6,064 |
5,642 |
$69K |
| 93350 |
|
497 |
474 |
$69K |
| 74178 |
|
522 |
507 |
$68K |
| 96367 |
|
2,419 |
1,992 |
$65K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
18,265 |
14,884 |
$65K |
| 82306 |
Vitamin D; 25 hydroxy, includes fraction(s), if performed |
12,149 |
11,658 |
$63K |
| 93922 |
|
1,311 |
1,258 |
$63K |
| 36430 |
|
787 |
624 |
$62K |
| 86780 |
|
9,812 |
9,485 |
$62K |
| 85027 |
|
55,231 |
46,456 |
$61K |
| 74230 |
|
1,214 |
1,170 |
$60K |
| 95923 |
|
784 |
767 |
$60K |
| 77338 |
|
101 |
90 |
$60K |
| 80076 |
|
21,003 |
15,905 |
$59K |
| 80061 |
Lipid panel |
19,719 |
18,908 |
$58K |
| 96136 |
|
717 |
696 |
$58K |
| 93320 |
|
3,330 |
3,187 |
$57K |
| J7298 |
Levonorgestrel-releasing intrauterine contraceptive system (mirena), 52 mg |
178 |
169 |
$56K |
| 87536 |
|
1,780 |
1,724 |
$55K |
| 94010 |
|
5,567 |
5,180 |
$54K |
| 96131 |
|
594 |
576 |
$53K |
| 76813 |
|
1,633 |
1,589 |
$52K |
| 75561 |
|
277 |
269 |
$52K |
| 95885 |
|
504 |
492 |
$52K |
| 88185 |
|
891 |
797 |
$51K |
| 94060 |
|
1,343 |
1,299 |
$51K |
| 86834 |
|
3,845 |
3,502 |
$50K |
| 12001 |
|
310 |
297 |
$49K |
| G0480 |
Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed |
4,651 |
4,198 |
$49K |
| 82105 |
|
7,349 |
6,989 |
$49K |
| 87497 |
|
4,308 |
2,405 |
$49K |
| 93880 |
|
1,046 |
991 |
$49K |
| G0009 |
Administration of pneumococcal vaccine |
4,474 |
4,391 |
$48K |
| 30520 |
|
131 |
129 |
$48K |
| 73030 |
|
7,795 |
6,606 |
$48K |
| 83605 |
|
10,683 |
9,377 |
$46K |
| 83036 |
Hemoglobin; glycosylated (A1C) |
23,363 |
22,425 |
$46K |
| 87491 |
Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe |
12,586 |
11,711 |
$45K |
| 97166 |
|
1,412 |
1,365 |
$45K |
| 77067 |
Screening mammography, bilateral, including computer-aided detection |
4,781 |
4,715 |
$45K |
| 51705 |
|
461 |
420 |
$45K |
| 95117 |
|
2,597 |
1,448 |
$44K |
| 88142 |
|
3,759 |
3,700 |
$43K |
| 87624 |
Infectious agent detection by nucleic acid; human papillomavirus (HPV), high-risk types |
4,247 |
4,167 |
$43K |
| 83735 |
|
53,202 |
37,179 |
$43K |
| 90834 |
Psychotherapy, 45 minutes with patient |
972 |
537 |
$42K |
| 86480 |
|
4,200 |
4,071 |
$41K |
| 90686 |
|
4,939 |
4,865 |
$41K |
| 97116 |
|
2,478 |
1,703 |
$40K |
| 94660 |
|
211 |
127 |
$40K |
| 87799 |
|
4,148 |
3,280 |
$39K |
| 72125 |
Computed tomography, cervical spine; without contrast material |
4,225 |
3,969 |
$39K |
| 10060 |
|
273 |
266 |
$39K |
| 94729 |
|
3,701 |
3,575 |
$39K |
| 29888 |
|
13 |
13 |
$39K |
| 45378 |
Colonoscopy, flexible; diagnostic, including collection of specimen(s) |
91 |
83 |
$39K |
| 87507 |
|
691 |
663 |
$39K |
| 20550 |
|
228 |
216 |
$38K |
| 93454 |
|
42 |
41 |
$38K |
| 73564 |
|
6,741 |
5,330 |
$38K |
| 97542 |
|
1,675 |
1,429 |
$38K |
| 99291 |
Critical care, evaluation and management of the critically ill patient, first 30-74 minutes |
928 |
896 |
$38K |
| C9399 |
Unclassified drugs or biologicals |
2,697 |
2,275 |
$37K |
| 87522 |
Neg quan hep c or qual rna |
3,144 |
2,975 |
$37K |
| 94770 |
|
444 |
428 |
$36K |
| 10061 |
|
184 |
175 |
$36K |
| J0185 |
Injection, aprepitant, 1 mg |
502 |
362 |
$36K |
| J3490 |
Unclassified drugs |
8,632 |
6,741 |
$34K |
| 82728 |
|
12,683 |
12,179 |
$34K |
| 77002 |
|
577 |
547 |
$34K |
| 96158 |
|
379 |
272 |
$34K |
| 52310 |
|
64 |
62 |
$33K |
| 70544 |
|
302 |
291 |
$33K |
| 73130 |
|
4,894 |
3,912 |
$33K |
| 84439 |
|
8,831 |
8,354 |
$32K |
| 11045 |
|
146 |
76 |
$32K |
| 85610 |
|
52,115 |
40,174 |
$32K |
| 87040 |
|
5,833 |
5,031 |
$31K |
| 74420 |
|
499 |
481 |
$31K |
| 96374 |
Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance |
25,180 |
21,581 |
$30K |
| 91200 |
|
501 |
478 |
$30K |
| 90674 |
|
2,270 |
2,229 |
$29K |
| 71045 |
Radiologic examination, chest; single view |
16,976 |
15,205 |
$29K |
| 73110 |
|
4,770 |
4,040 |
$29K |
| 82784 |
|
6,382 |
3,793 |
$29K |
| 72157 |
|
976 |
943 |
$29K |
| 94726 |
|
1,258 |
1,221 |
$29K |
| 70498 |
|
1,751 |
1,690 |
$29K |
| 90670 |
|
2,816 |
2,761 |
$29K |
| 95924 |
|
736 |
720 |
$28K |
| 92567 |
|
3,122 |
3,044 |
$28K |
| 72100 |
|
3,625 |
3,454 |
$28K |
| 86835 |
|
3,845 |
3,502 |
$28K |
| 82607 |
|
7,258 |
7,040 |
$27K |
| 87517 |
|
2,528 |
2,394 |
$27K |
| 87086 |
Culture, bacterial; quantitative colony count, urine |
25,943 |
23,117 |
$27K |
| 37243 |
|
37 |
36 |
$27K |
| 73630 |
|
4,133 |
3,461 |
$26K |
| 70487 |
|
176 |
169 |
$26K |
| 82533 |
|
2,734 |
2,141 |
$26K |
| 87631 |
|
1,626 |
1,557 |
$26K |
| 73700 |
|
486 |
429 |
$26K |
| 93976 |
|
286 |
273 |
$26K |
| 95886 |
|
429 |
424 |
$25K |
| 84403 |
|
2,915 |
2,803 |
$25K |
| 90677 |
|
1,003 |
987 |
$24K |
| 77301 |
|
86 |
77 |
$24K |
| 93246 |
|
841 |
784 |
$23K |
| J9217 |
Leuprolide acetate (for depot suspension), 7.5 mg |
149 |
130 |
$23K |
| 86140 |
|
12,237 |
11,310 |
$23K |
| 95816 |
|
200 |
191 |
$23K |
| 86235 |
|
3,005 |
1,733 |
$23K |
| 93242 |
|
910 |
876 |
$23K |
| 96112 |
|
34 |
34 |
$22K |
| 86304 |
|
2,784 |
2,311 |
$22K |
| 90792 |
Psychiatric diagnostic evaluation with medical services |
612 |
588 |
$22K |
| 77001 |
|
430 |
395 |
$22K |
| 86803 |
|
11,405 |
10,972 |
$22K |
| 82570 |
|
17,149 |
14,231 |
$22K |
| 29075 |
|
84 |
74 |
$21K |
| 92579 |
|
428 |
399 |
$21K |
| 80069 |
|
5,004 |
4,413 |
$21K |
| 86923 |
|
1,368 |
1,170 |
$20K |
| 73502 |
|
2,959 |
2,803 |
$20K |
| 84270 |
|
2,548 |
2,450 |
$20K |
| 72131 |
|
1,317 |
1,278 |
$19K |
| 64483 |
|
54 |
53 |
$19K |
| 84702 |
|
15,340 |
13,600 |
$19K |
| 11056 |
|
288 |
252 |
$19K |
| 10005 |
|
75 |
69 |
$19K |
| 81001 |
|
55,694 |
48,544 |
$19K |
| 82670 |
|
1,672 |
1,616 |
$18K |
| 73140 |
|
2,568 |
2,234 |
$18K |
| 97167 |
|
471 |
454 |
$18K |
| 11721 |
|
1,245 |
1,197 |
$18K |
| 72195 |
|
111 |
108 |
$18K |
| 87389 |
Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies |
10,616 |
10,236 |
$17K |
| 51702 |
|
1,479 |
1,303 |
$17K |
| 82785 |
|
2,478 |
2,412 |
$17K |
| 78306 |
|
96 |
95 |
$17K |
| 90648 |
|
1,119 |
1,101 |
$17K |
| 85379 |
|
4,609 |
4,382 |
$17K |
| 74018 |
|
1,806 |
1,571 |
$17K |
| 87340 |
|
9,677 |
9,279 |
$17K |
| 73610 |
|
3,522 |
2,987 |
$17K |
| 20680 |
|
13 |
12 |
$16K |
| 94640 |
Pressurized or nonpressurized inhalation treatment for acute airway obstruction |
2,710 |
2,111 |
$16K |
| 88342 |
|
4,437 |
4,172 |
$16K |
| 72110 |
|
1,473 |
1,427 |
$16K |
| 99392 |
Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) |
418 |
417 |
$15K |
| 84146 |
|
1,743 |
1,675 |
$15K |
| 99391 |
Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) |
473 |
446 |
$15K |
| 52356 |
|
14 |
13 |
$15K |
| 72040 |
|
1,754 |
1,661 |
$15K |
| 11055 |
|
188 |
174 |
$14K |
| 86141 |
|
7,569 |
7,180 |
$14K |
| 51798 |
|
3,746 |
3,538 |
$14K |
| 84466 |
|
9,084 |
8,684 |
$14K |
| 88341 |
|
2,819 |
2,352 |
$14K |
| 87661 |
Infectious agent detection by nucleic acid; Trichomonas vaginalis, amplified probe |
2,730 |
2,640 |
$14K |
| 90688 |
|
1,481 |
1,473 |
$14K |
| 84100 |
|
27,153 |
17,487 |
$14K |
| 86695 |
|
2,178 |
2,075 |
$14K |
| 83001 |
|
1,698 |
1,655 |
$13K |
| 86850 |
|
11,279 |
10,564 |
$13K |
| 95908 |
|
103 |
102 |
$13K |
| 76820 |
|
714 |
342 |
$13K |
| 58558 |
|
12 |
12 |
$13K |
| 92611 |
|
375 |
359 |
$13K |
| 85652 |
|
16,377 |
15,449 |
$13K |
| G2215 |
Take-home supply of nasal naloxone; 2-pack of 4mg per 0.1 ml nasal spray (provision of the services by a medicare-enrolled opioid treatment program); list separately in addition to code for primary procedure |
288 |
279 |
$12K |
| 0124A |
|
501 |
493 |
$12K |
| 73120 |
|
2,066 |
1,113 |
$12K |
| 64493 |
|
25 |
24 |
$12K |
| 83520 |
|
5,556 |
3,546 |
$12K |
| 80180 |
|
3,241 |
2,475 |
$12K |
| 93247 |
|
533 |
506 |
$12K |
| 86003 |
|
2,762 |
2,247 |
$12K |
| 0011A |
|
461 |
458 |
$12K |
| 83540 |
|
9,345 |
8,928 |
$12K |
| 62369 |
|
249 |
220 |
$12K |
| 0001A |
|
449 |
443 |
$12K |
| 86900 |
|
13,091 |
11,554 |
$12K |
| 96375 |
Therapeutic injection; each additional sequential IV push |
24,160 |
18,917 |
$12K |
| C1713 |
Anchor/screw for opposing bone-to-bone or soft tissue-to-bone (implantable) |
3,445 |
3,208 |
$11K |
| 77332 |
|
116 |
107 |
$11K |
| 91299 |
|
180 |
166 |
$11K |
| 88313 |
|
2,018 |
1,632 |
$11K |
| C1769 |
Guide wire |
10,863 |
9,235 |
$11K |
| 76376 |
|
3,678 |
3,523 |
$11K |
| P9047 |
Infusion, albumin (human), 25%, 50 ml |
83 |
50 |
$11K |
| 86360 |
|
1,371 |
1,321 |
$11K |
| 76881 |
|
152 |
147 |
$11K |
| 86706 |
|
7,033 |
6,708 |
$11K |
| 90480 |
|
998 |
974 |
$11K |
| 93226 |
|
324 |
321 |
$11K |
| 82746 |
|
4,429 |
4,301 |
$10K |
| 82977 |
|
9,642 |
6,338 |
$10K |
| 12002 |
|
72 |
65 |
$10K |
| 90853 |
Group psychotherapy (other than of a multiple-family group) |
481 |
152 |
$10K |
| C1887 |
Catheter, guiding (may include infusion/perfusion capability) |
3,760 |
3,400 |
$10K |
| 99393 |
Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) |
316 |
314 |
$10K |
| 36556 |
|
13 |
13 |
$10K |
| 83516 |
|
4,415 |
2,677 |
$10K |
| 73080 |
|
2,220 |
1,982 |
$10K |
| 87116 |
|
1,421 |
1,202 |
$10K |
| G0481 |
Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 8-14 drug class(es), including metabolite(s) if performed |
412 |
384 |
$10K |
| 86255 |
|
1,066 |
1,007 |
$10K |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
258 |
249 |
$10K |
| 87081 |
|
6,378 |
6,145 |
$9K |
| 92610 |
|
467 |
422 |
$9K |
| 90846 |
Family psychotherapy without the patient present, 50 minutes |
78 |
69 |
$9K |
| 86038 |
|
5,227 |
5,068 |
$9K |
| 91322 |
|
703 |
691 |
$9K |
| 73562 |
|
814 |
611 |
$9K |
| Q5118 |
Injection, bevacizumab-bvzr, biosimilar, (zirabev), 10 mg |
31 |
12 |
$9K |
| 86704 |
|
5,548 |
5,307 |
$9K |
| 64415 |
|
56 |
54 |
$9K |
| 77280 |
|
66 |
51 |
$9K |
| 84156 |
|
14,031 |
11,171 |
$9K |
| 86762 |
|
3,770 |
3,621 |
$9K |
| 74241 |
|
114 |
113 |
$9K |
| 87800 |
|
1,644 |
1,590 |
$9K |
| 88184 |
|
939 |
850 |
$9K |
| J2704 |
Injection, propofol, 10 mg |
39,698 |
30,196 |
$9K |
| 88350 |
|
1,357 |
1,094 |
$8K |
| Q9967 |
Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml |
36,933 |
33,453 |
$8K |
| 86481 |
|
698 |
666 |
$8K |
| 99394 |
Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) |
201 |
200 |
$8K |
| 86665 |
|
2,148 |
1,210 |
$8K |
| 86256 |
|
729 |
712 |
$8K |
| 93243 |
|
356 |
348 |
$8K |
| 83050 |
|
1,194 |
802 |
$8K |
| J1453 |
Injection, fosaprepitant, 1 mg |
65 |
50 |
$8K |
| 97130 |
|
961 |
659 |
$8K |
| 92526 |
|
291 |
253 |
$8K |
| 86355 |
|
1,293 |
1,251 |
$8K |
| 80195 |
|
1,268 |
940 |
$8K |
| 84153 |
|
3,057 |
2,842 |
$8K |
| 88304 |
|
3,276 |
2,871 |
$8K |
| 17003 |
|
476 |
430 |
$8K |
| 84630 |
|
1,226 |
1,180 |
$8K |
| 70543 |
|
52 |
50 |
$8K |
| 86901 |
|
13,402 |
11,819 |
$8K |
| 64447 |
|
92 |
91 |
$8K |
| 62323 |
|
37 |
37 |
$7K |
| 86644 |
|
1,551 |
1,456 |
$7K |
| 80143 |
|
2,127 |
1,929 |
$7K |
| 83010 |
|
1,969 |
1,480 |
$7K |
| C1751 |
Catheter, infusion, inserted peripherally, centrally or midline (other than hemodialysis) |
1,972 |
1,768 |
$7K |
| 87077 |
|
9,480 |
6,846 |
$7K |
| 11720 |
|
606 |
569 |
$7K |
| 82542 |
|
1,128 |
1,099 |
$7K |
| 88312 |
|
1,952 |
1,718 |
$7K |
| 96368 |
|
318 |
260 |
$7K |
| 78999 |
|
252 |
197 |
$7K |
| 95910 |
|
49 |
48 |
$7K |
| 51741 |
|
340 |
325 |
$7K |
| 84163 |
|
632 |
619 |
$7K |
| 73560 |
|
2,326 |
1,885 |
$7K |
| 72128 |
|
873 |
850 |
$7K |
| J2405 |
Injection, ondansetron hydrochloride, per 1 mg |
44,803 |
36,976 |
$7K |
| 87186 |
|
8,798 |
7,944 |
$7K |
| 36248 |
|
21 |
12 |
$7K |
| 72050 |
|
608 |
591 |
$7K |
| 82550 |
|
5,735 |
5,229 |
$6K |
| 96137 |
|
715 |
693 |
$6K |
| 87070 |
|
6,644 |
6,118 |
$6K |
| 81479 |
Unlisted molecular pathology procedure |
188 |
183 |
$6K |
| C1894 |
Introducer/sheath, other than guiding, other than intracardiac electrophysiological, non-laser |
8,212 |
7,260 |
$6K |
| 88346 |
|
1,224 |
1,149 |
$6K |
| 72146 |
|
162 |
161 |
$6K |
| C8928 |
Transthoracic echocardiography with contrast, or without contrast followed by with contrast, real-time with image documentation (2d), includes m-mode recording, when performed, during rest and cardiovascular stress test using treadmill, bicycle exercise and/or pharmacologically induced stress, with interpretation and report |
33 |
30 |
$6K |
| 83690 |
|
21,054 |
18,671 |
$6K |
| 96138 |
|
12 |
12 |
$6K |
| 94621 |
|
71 |
71 |
$6K |
| 76857 |
|
127 |
123 |
$6K |
| 0002A |
|
188 |
185 |
$6K |
| 82565 |
|
3,581 |
3,309 |
$6K |
| 85730 |
|
22,988 |
20,579 |
$6K |
| 93351 |
|
37 |
36 |
$6K |
| 83002 |
|
910 |
884 |
$6K |
| 86696 |
|
2,205 |
2,100 |
$6K |
| 51700 |
|
119 |
105 |
$6K |
| Q9957 |
Injection, perflutren lipid microspheres, per ml |
2,497 |
2,346 |
$5K |
| C1874 |
Stent, coated/covered, with delivery system |
569 |
537 |
$5K |
| 97035 |
|
826 |
464 |
$5K |
| 73590 |
|
1,769 |
1,554 |
$5K |
| G0108 |
Diabetes outpatient self-management training services, individual, per 30 minutes |
93 |
69 |
$5K |
| 96150 |
|
67 |
66 |
$5K |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
247 |
245 |
$5K |
| 0297T |
|
316 |
312 |
$5K |
| 76377 |
|
2,207 |
2,139 |
$5K |
| 86359 |
|
625 |
606 |
$5K |
| 86664 |
|
1,232 |
1,159 |
$5K |
| 36591 |
|
2,110 |
1,471 |
$5K |
| 88108 |
|
1,707 |
1,319 |
$5K |
| 96101 |
|
12 |
12 |
$5K |
| 84480 |
|
1,964 |
1,867 |
$5K |
| 86334 |
|
882 |
846 |
$5K |
| 93662 |
|
37 |
37 |
$5K |
| 85014 |
|
3,360 |
2,840 |
$5K |
| U0002 |
2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc |
563 |
530 |
$5K |
| 84165 |
|
2,397 |
2,273 |
$5K |
| 85018 |
|
6,467 |
5,688 |
$5K |
| 82103 |
|
634 |
616 |
$5K |
| 90750 |
|
132 |
130 |
$5K |
| 90734 |
|
505 |
502 |
$5K |
| 72070 |
|
555 |
530 |
$5K |
| 90935 |
Hemodialysis procedure with single evaluation by a physician |
22 |
13 |
$5K |
| J0881 |
Injection, darbepoetin alfa, 1 microgram (non-esrd use) |
30 |
25 |
$5K |
| 86769 |
|
384 |
368 |
$5K |
| 93926 |
|
56 |
55 |
$5K |
| 93750 |
|
101 |
70 |
$4K |
| 0241U |
Neonatal screening for hereditary disorders, genomic sequence analysis panel |
7,908 |
7,463 |
$4K |
| 86160 |
|
2,548 |
2,450 |
$4K |
| J2250 |
Injection, midazolam hydrochloride, per 1 mg |
26,491 |
24,998 |
$4K |
| 86376 |
|
298 |
289 |
$4K |
| 91321 |
|
223 |
217 |
$4K |
| 90832 |
Psychotherapy, 30 minutes with patient |
225 |
186 |
$4K |
| J7120 |
Ringers lactate infusion, up to 1000 cc |
38,297 |
31,427 |
$4K |
| 87205 |
|
9,379 |
8,654 |
$4K |
| 82077 |
|
10,857 |
9,438 |
$4K |
| Q0111 |
Wet mounts, including preparations of vaginal, cervical or skin specimens |
383 |
373 |
$4K |
| 86708 |
|
2,922 |
2,798 |
$4K |
| 82950 |
|
2,732 |
2,468 |
$4K |
| 73620 |
|
519 |
311 |
$4K |
| 86777 |
|
1,118 |
1,041 |
$4K |
| 93225 |
|
318 |
311 |
$4K |
| 90791 |
Psychiatric diagnostic evaluation |
396 |
375 |
$4K |
| 80164 |
|
981 |
863 |
$4K |
| 58301 |
|
41 |
40 |
$4K |
| 82248 |
|
2,086 |
1,949 |
$4K |
| C1725 |
Catheter, transluminal angioplasty, non-laser (may include guidance, infusion/perfusion capability) |
1,563 |
1,447 |
$4K |
| 90732 |
|
479 |
469 |
$4K |
| 82043 |
|
5,007 |
4,786 |
$4K |
| 86787 |
|
2,359 |
2,250 |
$4K |
| 73090 |
|
1,126 |
1,018 |
$4K |
| 82390 |
|
836 |
812 |
$4K |
| C1776 |
Joint device (implantable) |
817 |
797 |
$4K |
| 82375 |
|
1,385 |
959 |
$4K |
| 74240 |
|
54 |
54 |
$4K |
| 77370 |
|
27 |
26 |
$4K |
| 58100 |
|
14 |
14 |
$4K |
| 50200 |
|
14 |
12 |
$4K |
| 95115 |
|
185 |
104 |
$4K |
| 89051 |
|
1,394 |
1,274 |
$4K |
| 99395 |
Periodic comprehensive preventive medicine reevaluation, established patient, 18-39 years |
281 |
280 |
$3K |
| 86317 |
|
383 |
283 |
$3K |
| 98968 |
|
887 |
847 |
$3K |
| 91035 |
|
22 |
13 |
$3K |
| 83615 |
|
5,878 |
4,524 |
$3K |
| 86833 |
|
180 |
173 |
$3K |
| 93925 |
|
83 |
76 |
$3K |
| 86832 |
|
168 |
162 |
$3K |
| 77065 |
Tomosynthesis, mammo |
121 |
116 |
$3K |
| 96450 |
|
16 |
12 |
$3K |
| 92978 |
|
143 |
137 |
$3K |
| 93798 |
|
800 |
166 |
$3K |
| 11101 |
|
145 |
143 |
$3K |
| Q9968 |
Injection, non-radioactive, non-contrast, visualization adjunct (e.g., methylene blue, isosulfan blue), 1 mg |
279 |
261 |
$3K |
| 93356 |
|
1,470 |
1,385 |
$3K |
| 82677 |
|
162 |
158 |
$3K |
| 57456 |
|
12 |
12 |
$3K |
| 86431 |
|
2,855 |
2,775 |
$3K |
| 72142 |
|
320 |
315 |
$3K |
| 0054A |
|
110 |
110 |
$3K |
| 71271 |
|
39 |
38 |
$3K |
| 90707 |
|
391 |
382 |
$3K |
| 92504 |
|
344 |
335 |
$3K |
| 86200 |
|
2,361 |
2,301 |
$3K |
| C1726 |
Catheter, balloon dilatation, non-vascular |
1,411 |
1,332 |
$3K |
| J0690 |
Injection, cefazolin sodium, 500 mg |
13,570 |
11,297 |
$3K |
| 90636 |
|
180 |
171 |
$3K |
| 70546 |
|
17 |
17 |
$3K |
| 95819 |
|
14 |
14 |
$3K |
| 88112 |
|
1,881 |
1,759 |
$3K |
| J1170 |
Injection, hydromorphone, up to 4 mg |
15,501 |
11,340 |
$3K |
| 97804 |
|
187 |
178 |
$3K |
| 86147 |
|
337 |
300 |
$3K |
| 0296T |
|
398 |
385 |
$3K |
| 88323 |
|
135 |
132 |
$3K |
| 81025 |
|
8,323 |
7,909 |
$3K |
| 84550 |
|
4,148 |
3,655 |
$3K |
| 87046 |
|
962 |
917 |
$3K |
| 80178 |
|
504 |
471 |
$3K |
| 77066 |
Tomosynthesis, mammo |
106 |
105 |
$3K |
| 96116 |
|
12 |
12 |
$3K |
| 86828 |
|
248 |
229 |
$3K |
| 83521 |
|
1,188 |
568 |
$3K |
| 95874 |
|
2,365 |
2,244 |
$3K |
| 82803 |
|
4,213 |
3,695 |
$3K |
| J0696 |
Injection, ceftriaxone sodium, per 250 mg |
8,080 |
6,717 |
$2K |
| 72082 |
|
224 |
212 |
$2K |
| 87147 |
|
3,512 |
2,860 |
$2K |
| 82947 |
|
2,531 |
2,372 |
$2K |
| 80179 |
|
1,441 |
1,313 |
$2K |
| 0064A |
|
116 |
114 |
$2K |
| 92552 |
|
25 |
25 |
$2K |
| 86225 |
|
2,058 |
1,998 |
$2K |
| 80306 |
|
3,154 |
2,956 |
$2K |
| 90662 |
|
798 |
779 |
$2K |
| 96376 |
|
8,483 |
6,549 |
$2K |
| 80162 |
|
285 |
208 |
$2K |
| 87102 |
|
3,330 |
3,165 |
$2K |
| 51728 |
|
12 |
12 |
$2K |
| 92083 |
|
671 |
656 |
$2K |
| 86146 |
|
338 |
301 |
$2K |
| 11103 |
|
78 |
70 |
$2K |
| J3010 |
Injection, fentanyl citrate, 0.1 mg |
25,689 |
22,006 |
$2K |
| 87015 |
|
2,288 |
2,027 |
$2K |
| 12011 |
|
12 |
12 |
$2K |
| 73222 |
|
13 |
12 |
$2K |
| 92587 |
|
25 |
25 |
$2K |
| 90656 |
|
552 |
544 |
$2K |
| 84134 |
|
1,283 |
1,135 |
$2K |
| A9552 |
Fluorodeoxyglucose f-18 fdg, diagnostic, per study dose, up to 45 millicuries |
1,488 |
1,455 |
$2K |
| 86765 |
|
1,533 |
1,448 |
$2K |
| 0004A |
|
77 |
75 |
$2K |
| 82525 |
|
355 |
343 |
$2K |
| 82962 |
|
17,021 |
12,324 |
$2K |
| 73701 |
|
13 |
12 |
$2K |
| 73200 |
|
24 |
24 |
$2K |
| 86364 |
|
763 |
752 |
$2K |
| 87593 |
|
33 |
31 |
$2K |
| 86735 |
|
1,240 |
1,163 |
$2K |
| 87075 |
|
3,248 |
2,989 |
$2K |
| 87088 |
|
3,358 |
2,948 |
$2K |
| C1730 |
Catheter, electrophysiology, diagnostic, other than 3d mapping (19 or fewer electrodes) |
1,175 |
1,085 |
$2K |
| 0154A |
|
45 |
45 |
$2K |
| 75574 |
|
12 |
12 |
$2K |
| C1753 |
Catheter, intravascular ultrasound |
799 |
756 |
$2K |
| 88348 |
|
80 |
76 |
$2K |
| 72170 |
|
601 |
575 |
$2K |
| 0031A |
|
40 |
39 |
$2K |
| 73552 |
|
673 |
581 |
$2K |
| A9579 |
Injection, gadolinium-based magnetic resonance contrast agent, not otherwise specified (nos), per ml |
13,928 |
13,220 |
$2K |
| 88360 |
|
161 |
133 |
$2K |
| 69210 |
|
27 |
27 |
$2K |
| 75572 |
|
13 |
12 |
$1K |
| C1760 |
Closure device, vascular (implantable/insertable) |
1,786 |
1,609 |
$1K |
| J1885 |
Injection, ketorolac tromethamine, per 15 mg |
14,795 |
12,200 |
$1K |
| 85384 |
|
1,803 |
1,542 |
$1K |
| 83051 |
|
778 |
479 |
$1K |
| 82150 |
|
731 |
652 |
$1K |
| 84481 |
|
495 |
468 |
$1K |
| 92523 |
|
12 |
12 |
$1K |
| 97760 |
|
54 |
51 |
$1K |
| 92133 |
|
987 |
954 |
$1K |
| 92537 |
|
31 |
26 |
$1K |
| 73521 |
|
123 |
116 |
$1K |
| 70549 |
|
13 |
13 |
$1K |
| 86258 |
|
453 |
449 |
$1K |
| 76819 |
Fetal biophysical profile; without non-stress testing |
45 |
25 |
$1K |
| 80047 |
|
546 |
525 |
$1K |
| 81002 |
|
2,067 |
1,892 |
$1K |
| 75565 |
|
420 |
406 |
$1K |
| 95909 |
|
13 |
12 |
$1K |
| 84295 |
|
2,098 |
1,725 |
$1K |
| 74328 |
|
24 |
24 |
$1K |
| 99001 |
|
97 |
96 |
$1K |
| 82140 |
|
491 |
444 |
$1K |
| J7050 |
Infusion, normal saline solution, 250 cc |
20,482 |
13,848 |
$1K |
| A9541 |
Technetium tc-99m sulfur colloid, diagnostic, per study dose, up to 20 millicuries |
784 |
756 |
$1K |
| 0111A |
|
27 |
24 |
$1K |
| J7030 |
Infusion, normal saline solution , 1000 cc |
15,489 |
11,728 |
$1K |
| 73060 |
|
608 |
539 |
$1K |
| 82575 |
|
794 |
770 |
$1K |
| 84166 |
|
150 |
143 |
$1K |
| 83655 |
|
94 |
94 |
$1K |
| 0081A |
|
25 |
25 |
$1K |
| 82274 |
|
263 |
261 |
$1K |
| 77331 |
|
27 |
24 |
$988.44 |
| 88300 |
|
753 |
654 |
$976.67 |
| 82365 |
|
160 |
152 |
$975.25 |
| 84202 |
|
75 |
72 |
$968.52 |
| J3370 |
Injection, vancomycin hcl, 500 mg |
5,174 |
3,269 |
$946.82 |
| 84305 |
|
109 |
107 |
$899.83 |
| 96132 |
|
13 |
13 |
$899.51 |
| 76872 |
|
27 |
26 |
$875.25 |
| 82378 |
|
196 |
167 |
$864.55 |
| 82330 |
|
2,245 |
1,791 |
$862.18 |
| 86357 |
|
124 |
123 |
$837.83 |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
14,926 |
13,573 |
$837.28 |
| 86036 |
|
638 |
624 |
$834.33 |
| G0103 |
Prostate cancer screening; prostate specific antigen test (psa) |
293 |
288 |
$818.84 |
| 82805 |
|
333 |
318 |
$803.41 |
| 90746 |
|
55 |
49 |
$800.28 |
| J3489 |
Injection, zoledronic acid, 1 mg |
15 |
14 |
$797.30 |
| J3111 |
Injection, romosozumab-aqqg, 1 mg |
13 |
13 |
$795.87 |
| 99202 |
Office or other outpatient visit for the evaluation and management of a new patient, straightforward |
39 |
38 |
$795.71 |
| J1642 |
Injection, heparin sodium, (heparin lock flush), per 10 units |
1,976 |
684 |
$783.03 |
| 84460 |
|
1,099 |
1,027 |
$761.36 |
| Q0112 |
All potassium hydroxide (koh) preparations |
108 |
108 |
$757.28 |
| 83013 |
|
38 |
38 |
$718.39 |
| J2785 |
Injection, regadenoson, 0.1 mg |
1,431 |
1,352 |
$704.28 |
| 87801 |
Infectious agent detection by nucleic acid; amplified probe, multiple organisms |
177 |
169 |
$702.04 |
| 85046 |
|
1,746 |
1,278 |
$696.38 |
| 88720 |
|
194 |
166 |
$695.73 |
| 84450 |
|
796 |
729 |
$693.43 |
| 94799 |
|
242 |
238 |
$676.92 |
| 80305 |
|
330 |
318 |
$671.07 |
| 87206 |
|
1,309 |
1,180 |
$669.45 |
| 84378 |
|
408 |
401 |
$665.09 |
| J1650 |
Injection, enoxaparin sodium, 10 mg |
5,743 |
2,604 |
$662.02 |
| 96159 |
|
299 |
214 |
$639.16 |
| 99385 |
|
12 |
12 |
$626.49 |
| 87633 |
Infectious agent detection by nucleic acid, respiratory virus, 12-25 targets |
12 |
12 |
$617.40 |
| 84132 |
|
2,760 |
2,418 |
$613.32 |
| 82247 |
|
279 |
244 |
$606.74 |
| 84446 |
|
223 |
216 |
$603.95 |
| 62370 |
|
16 |
15 |
$600.07 |
| 93280 |
|
102 |
97 |
$587.08 |
| 92540 |
|
31 |
26 |
$585.79 |
| J1644 |
Injection, heparin sodium, per 1000 units |
10,160 |
5,708 |
$585.26 |
| J0171 |
Injection, adrenalin, epinephrine, 0.1 mg |
2,752 |
2,535 |
$582.29 |
| 86015 |
|
245 |
239 |
$581.99 |
| 87210 |
|
1,284 |
1,202 |
$572.44 |
| J2765 |
Injection, metoclopramide hcl, up to 10 mg |
4,724 |
4,044 |
$569.02 |
| 88738 |
|
200 |
190 |
$567.55 |
| J3301 |
Injection, triamcinolone acetonide, not otherwise specified, 10 mg |
6,731 |
6,225 |
$554.28 |
| 80175 |
|
123 |
119 |
$549.25 |
| G0279 |
Diagnostic digital breast tomosynthesis, unilateral or bilateral (list separately in addition to 77065 or 77066) |
145 |
137 |
$545.81 |
| 93041 |
|
3,772 |
3,378 |
$532.40 |
| 93010 |
Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only |
102 |
81 |
$529.83 |
| 86778 |
|
55 |
53 |
$520.25 |
| J2310 |
Injection, naloxone hydrochloride, per 1 mg |
51 |
42 |
$506.07 |
| 80299 |
|
85 |
65 |
$501.56 |
| 72147 |
|
189 |
187 |
$491.04 |
| 0072A |
|
12 |
12 |
$487.20 |
| 0003A |
|
22 |
22 |
$486.00 |
| 92548 |
|
14 |
14 |
$479.38 |
| C1729 |
Catheter, drainage |
1,609 |
1,265 |
$458.13 |
| 95004 |
Percutaneous tests with allergenic extracts, immediate type reaction |
663 |
652 |
$445.25 |
| 83020 |
|
121 |
112 |
$432.61 |
| 73522 |
|
58 |
56 |
$428.24 |
| A9502 |
Technetium tc-99m tetrofosmin, diagnostic, per study dose |
1,588 |
1,416 |
$420.34 |
| C2628 |
Catheter, occlusion |
490 |
473 |
$416.66 |
| 92551 |
|
13 |
13 |
$412.52 |
| 81003 |
|
963 |
750 |
$404.81 |
| 87181 |
|
303 |
280 |
$402.00 |
| J3475 |
Injection, magnesium sulfate, per 500 mg |
4,289 |
3,163 |
$401.39 |
| 96417 |
|
1,206 |
774 |
$381.61 |
| 82627 |
|
53 |
53 |
$381.06 |
| 87106 |
|
721 |
620 |
$374.67 |
| 86336 |
|
164 |
161 |
$372.62 |
| 81220 |
CFTR (cystic fibrosis transmembrane conductance regulator) gene analysis; common variants |
12 |
12 |
$372.20 |
| 0171A |
|
15 |
15 |
$368.40 |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
1,580 |
1,525 |
$366.59 |
| 86800 |
|
64 |
64 |
$365.27 |
| 94761 |
|
2,913 |
2,640 |
$360.66 |
| J0131 |
Injection, acetaminophen, not otherwise specified,10 mg |
4,967 |
4,740 |
$357.64 |
| 84590 |
|
154 |
145 |
$353.37 |
| 84080 |
|
79 |
74 |
$329.76 |
| 98967 |
|
242 |
234 |
$328.95 |
| 82465 |
|
241 |
221 |
$326.92 |
| C2625 |
Stent, non-coronary, temporary, with delivery system |
262 |
245 |
$324.68 |
| M0220 |
Injection, tixagevimab and cilgavimab, for the pre-exposure prophylaxis only, for certain adults and pediatric individuals (12 years of age and older weighing at least 40kg) with no known sars-cov-2 exposure, who either have moderate to severely compromised immune systems or for whom vaccination with any available covid-19 vaccine is not recommended due to a history of severe adverse reaction to a covid-19 vaccine(s) and/or covid-19 vaccine component(s), includes injection and post administration monitoring |
78 |
75 |
$314.97 |
| 96402 |
|
151 |
134 |
$308.91 |
| 51797 |
|
12 |
12 |
$305.92 |
| 86352 |
|
56 |
50 |
$301.04 |
| 90632 |
|
29 |
27 |
$298.00 |
| J1815 |
Injection, insulin, per 5 units |
5,151 |
2,584 |
$297.57 |
| 78205 |
|
35 |
26 |
$296.96 |
| 36600 |
|
124 |
121 |
$291.34 |
| J2930 |
Injection, methylprednisolone sodium succinate, up to 125 mg |
2,653 |
2,206 |
$289.23 |
| 86308 |
|
356 |
348 |
$288.84 |
| 73000 |
|
52 |
38 |
$288.56 |
| 86413 |
|
114 |
111 |
$276.81 |
| 87798 |
Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism |
67 |
65 |
$266.40 |
| 87184 |
|
681 |
639 |
$266.14 |
| 17312 |
|
18 |
14 |
$265.93 |
| J7040 |
Infusion, normal saline solution, sterile (500 ml = 1 unit) |
5,098 |
4,432 |
$256.62 |
| 82172 |
|
32 |
31 |
$248.52 |
| J0780 |
Injection, prochlorperazine, up to 10 mg |
1,852 |
1,532 |
$244.64 |
| 87176 |
|
410 |
369 |
$243.58 |
| 86592 |
|
153 |
147 |
$238.34 |
| J1200 |
Injection, diphenhydramine hcl, up to 50 mg |
4,715 |
3,478 |
$236.96 |
| J2270 |
Injection, morphine sulfate, up to 10 mg |
2,026 |
1,579 |
$236.44 |
| 81229 |
|
13 |
12 |
$229.20 |
| 86381 |
|
160 |
159 |
$227.49 |
| C1788 |
Port, indwelling (implantable) |
86 |
82 |
$222.58 |
| 83014 |
|
38 |
38 |
$219.78 |
| 80158 |
|
29 |
25 |
$217.07 |
| J2710 |
Injection, neostigmine methylsulfate, up to 0.5 mg |
2,476 |
2,388 |
$215.69 |
| 90678 |
|
75 |
74 |
$213.45 |
| 85670 |
|
753 |
723 |
$212.47 |
| 84425 |
|
59 |
58 |
$211.22 |
| 87481 |
|
44 |
41 |
$210.99 |
| 77091 |
|
60 |
58 |
$198.85 |
| 88173 |
|
471 |
366 |
$198.08 |
| 86870 |
|
32 |
25 |
$194.92 |
| 82945 |
|
203 |
178 |
$188.84 |
| G2066 |
Interrogation device evaluation(s), (remote) up to 30 days; implantable cardiovascular physiologic monitor system, implantable loop recorder system, or subcutaneous cardiac rhythm monitor system, remote data acquisition(s), receipt of transmissions and technician review, technical support and distribution of results |
12 |
12 |
$187.03 |
| 84157 |
|
200 |
170 |
$186.22 |
| C9290 |
Injection, bupivacaine liposome, 1 mg |
317 |
304 |
$183.17 |
| 83883 |
|
14 |
13 |
$179.46 |
| J0295 |
Injection, ampicillin sodium/sulbactam sodium, per 1.5 gm |
1,513 |
1,208 |
$178.19 |
| C1819 |
Surgical tissue localization and excision device (implantable) |
425 |
337 |
$176.46 |
| C2617 |
Stent, non-coronary, temporary, without delivery system |
787 |
750 |
$174.73 |
| 84145 |
|
13 |
12 |
$174.24 |
| 82010 |
|
626 |
536 |
$173.89 |
| 90694 |
|
299 |
292 |
$172.44 |
| 36592 |
|
184 |
152 |
$169.88 |
| 82104 |
|
27 |
26 |
$166.44 |
| 84478 |
|
284 |
210 |
$163.60 |
| 90474 |
|
800 |
788 |
$147.94 |
| 83021 |
|
47 |
38 |
$139.88 |
| J2003 |
Injection, lidocaine hydrochloride, 1 mg |
879 |
760 |
$137.28 |
| 82787 |
|
40 |
39 |
$136.31 |
| 87806 |
|
1,008 |
976 |
$136.06 |
| 73100 |
|
45 |
40 |
$130.25 |
| A9577 |
Injection, gadobenate dimeglumine (multihance), per ml |
1,198 |
1,054 |
$125.27 |
| 83993 |
|
12 |
12 |
$123.99 |
| J2795 |
Injection, ropivacaine hydrochloride, 1 mg |
1,040 |
961 |
$121.98 |
| 82085 |
|
42 |
41 |
$117.72 |
| J8501 |
Aprepitant, oral, 5 mg |
939 |
908 |
$116.82 |
| 82523 |
|
15 |
12 |
$115.82 |
| J1790 |
Injection, droperidol, up to 5 mg |
865 |
748 |
$114.43 |
| J1171 |
Injection, hydromorphone, 0.1 mg |
480 |
368 |
$114.40 |
| 96133 |
|
17 |
13 |
$108.88 |
| 90647 |
|
36 |
36 |
$107.80 |
| A9503 |
Technetium tc-99m medronate, diagnostic, per study dose, up to 30 millicuries |
478 |
453 |
$102.16 |
| 51701 |
|
175 |
169 |
$89.99 |
| J0330 |
Injection, succinylcholine chloride, up to 20 mg |
3,791 |
3,542 |
$88.96 |
| J3420 |
Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg |
160 |
131 |
$85.07 |
| J2370 |
Injection, phenylephrine hcl, up to 1 ml |
6,303 |
5,133 |
$83.90 |
| J1940 |
Injection, furosemide, up to 20 mg |
801 |
609 |
$83.20 |
| J7060 |
5% dextrose/water (500 ml = 1 unit) |
1,853 |
1,014 |
$81.87 |
| 82310 |
|
69 |
61 |
$80.91 |
| 86709 |
|
56 |
54 |
$80.34 |
| 85049 |
|
135 |
127 |
$77.62 |
| 91300 |
|
797 |
660 |
$77.58 |
| 96040 |
|
68 |
63 |
$71.59 |
| 82040 |
|
183 |
182 |
$69.20 |
| J0689 |
Injection, cefazolin sodium (baxter), not therapeutically equivalent to j0690, 500 mg |
1,743 |
1,430 |
$69.12 |
| J8540 |
Dexamethasone, oral, 0.25 mg |
881 |
519 |
$67.49 |
| 91301 |
|
494 |
489 |
$64.73 |
| 76000 |
|
54 |
52 |
$64.11 |
| J2060 |
Injection, lorazepam, 2 mg |
2,641 |
2,230 |
$60.96 |
| 82239 |
|
28 |
25 |
$59.15 |
| 87529 |
|
30 |
25 |
$58.94 |
| 84436 |
|
14 |
14 |
$54.76 |
| 84300 |
|
52 |
46 |
$54.20 |
| 94727 |
|
16 |
16 |
$53.52 |
| 87999 |
|
25 |
24 |
$52.48 |
| 94760 |
|
364 |
326 |
$52.28 |
| 87220 |
|
97 |
94 |
$47.92 |
| J0134 |
Injection, acetaminophen (fresenius kabi), not therapeutically equivalent to j0131, 10 mg |
1,792 |
1,685 |
$44.88 |
| 92134 |
|
31 |
31 |
$44.17 |
| 82166 |
|
14 |
14 |
$34.91 |
| 88302 |
|
16 |
13 |
$33.08 |
| J3480 |
Injection, potassium chloride, per 2 meq |
2,218 |
1,445 |
$32.08 |
| J1630 |
Injection, haloperidol, up to 5 mg |
1,195 |
1,059 |
$30.33 |
| J3360 |
Injection, diazepam, up to 5 mg |
249 |
213 |
$29.40 |
| 87493 |
|
12 |
12 |
$29.30 |
| 90716 |
|
176 |
171 |
$28.04 |
| 84681 |
|
14 |
12 |
$27.15 |
| A9270 |
Non-covered item or service |
32,488 |
8,009 |
$27.02 |
| A9555 |
Rubidium rb-82, diagnostic, per study dose, up to 60 millicuries |
52 |
50 |
$26.43 |
| A9540 |
Technetium tc-99m macroaggregated albumin, diagnostic, per study dose, up to 10 millicuries |
66 |
63 |
$25.11 |
| A9575 |
Injection, gadoterate meglumine, 0.1 ml |
789 |
763 |
$24.14 |
| 81000 |
|
445 |
425 |
$23.03 |
| C1892 |
Introducer/sheath, guiding, intracardiac electrophysiological, fixed-curve, peel-away |
33 |
31 |
$18.93 |
| 84520 |
|
12 |
12 |
$17.22 |
| J0702 |
Injection, betamethasone acetate 3 mg and betamethasone sodium phosphate 3 mg |
233 |
186 |
$16.81 |
| 82948 |
|
134 |
102 |
$15.29 |
| 86682 |
|
13 |
12 |
$14.91 |
| 83930 |
|
32 |
26 |
$14.29 |
| J7512 |
Prednisone, immediate release or delayed release, oral, 1 mg |
3,153 |
1,802 |
$14.17 |
| 0097U |
|
151 |
142 |
$13.54 |
| 90723 |
|
704 |
694 |
$8.92 |
| 85130 |
|
168 |
164 |
$8.10 |
| 81374 |
|
25 |
25 |
$7.38 |
| C1781 |
Mesh (implantable) |
264 |
259 |
$6.99 |
| J0665 |
Injection, bupivicaine, not otherwise specified, 0.5 mg |
974 |
868 |
$5.92 |
| 36416 |
|
1,362 |
994 |
$5.38 |
| C1758 |
Catheter, ureteral |
987 |
939 |
$4.76 |
| Q0162 |
Ondansetron 1 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy treatment, not to exceed a 48 hour dosage regimen |
561 |
494 |
$4.14 |
| Q9966 |
Low osmolar contrast material, 200-299 mg/ml iodine concentration, per ml |
1,393 |
1,288 |
$4.11 |
| J7620 |
Albuterol, up to 2.5 mg and ipratropium bromide, up to 0.5 mg, fda-approved final product, non-compounded, administered through dme |
1,021 |
700 |
$3.21 |
| J7613 |
Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose, 1 mg |
479 |
384 |
$2.20 |
| A4344 |
Indwelling catheter, foley type, two-way, all silicone or polyurethane, each |
51 |
48 |
$1.48 |
| 99072 |
|
86 |
74 |
$1.06 |
| J2920 |
Injection, methylprednisolone sodium succinate, up to 40 mg |
232 |
189 |
$0.72 |
| J1920 |
Injection, labetalol hydrochloride, 5 mg |
379 |
346 |
$0.64 |
| C2627 |
Catheter, suprapubic/cystoscopic |
81 |
62 |
$0.43 |
| Q0221 |
Injection, tixagevimab and cilgavimab, for the pre-exposure prophylaxis only, for certain adults and pediatric individuals (12 years of age and older weighing at least 40kg) with no known sars-cov-2 exposure, who either have moderate to severely compromised immune systems or for whom vaccination with any available covid-19 vaccine is not recommended due to a history of severe adverse reaction to a covid-19 vaccine(s) and/or covid-19 vaccine component(s), 600 mg |
79 |
75 |
$0.26 |
| J3411 |
Injection, thiamine hcl, 100 mg |
1,122 |
690 |
$0.20 |
| 90633 |
|
994 |
980 |
$0.01 |
| 90680 |
|
1,002 |
989 |
$0.00 |
| 90697 |
|
440 |
431 |
$0.00 |
| J2305 |
Injection, nitroglycerin, 5 mg |
221 |
209 |
$0.00 |
| S2900 |
Surgical techniques requiring use of robotic surgical system (list separately in addition to code for primary procedure) |
344 |
335 |
$0.00 |
| 90696 |
|
52 |
52 |
$0.00 |
| J1836 |
Injection, metronidazole, 10 mg |
497 |
389 |
$0.00 |
| 90381 |
|
41 |
41 |
$0.00 |
| A9698 |
Non-radioactive contrast imaging material, not otherwise classified, per study |
1,059 |
1,011 |
$0.00 |
| J9267 |
Injection, paclitaxel, 1 mg |
60 |
37 |
$0.00 |
| 81511 |
|
117 |
115 |
$0.00 |
| 91315 |
|
44 |
44 |
$0.00 |
| J2175 |
Injection, meperidine hydrochloride, per 100 mg |
226 |
212 |
$0.00 |
| J0360 |
Injection, hydralazine hcl, up to 20 mg |
260 |
230 |
$0.00 |
| J1250 |
Injection, dobutamine hydrochloride, per 250 mg |
26 |
24 |
$0.00 |
| G0010 |
Administration of hepatitis b vaccine |
99 |
95 |
$0.00 |
| U0005 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 |
2,616 |
1,996 |
$0.00 |
| J1805 |
Injection, esmolol hydrochloride, 10 mg |
59 |
55 |
$0.00 |
| 91317 |
|
69 |
68 |
$0.00 |
| 90698 |
|
109 |
108 |
$0.00 |
| C1759 |
Catheter, intracardiac echocardiography |
13 |
12 |
$0.00 |
| G8988 |
Self care functional limitation, projected goal status, at therapy episode outset, at reporting intervals, and at discharge or to end reporting |
17 |
15 |
$0.00 |
| J9045 |
Injection, carboplatin, 50 mg |
170 |
82 |
$0.00 |
| 91305 |
|
216 |
213 |
$0.00 |
| A4340 |
Indwelling catheter; specialty type, (e.g., coude, mushroom, wing, etc.), each |
14 |
13 |
$0.00 |
| J7507 |
Tacrolimus, immediate release, oral, 1 mg |
38 |
12 |
$0.00 |
| J0456 |
Injection, azithromycin, 500 mg |
20 |
17 |
$0.00 |
| J7042 |
5% dextrose/normal saline (500 ml = 1 unit) |
74 |
57 |
$0.00 |
| 38900 |
|
27 |
26 |
$0.00 |
| J0461 |
Injection, atropine sulfate, 0.01 mg |
12 |
12 |
$0.00 |
| G8991 |
Other physical or occupational therapy primary functional limitation, projected goal status, at therapy episode outset, at reporting intervals, and at discharge or to end reporting |
13 |
12 |
$0.00 |
| Q9965 |
Low osmolar contrast material, 100-199 mg/ml iodine concentration, per ml |
111 |
108 |
$0.00 |
| 88311 |
|
15 |
15 |
$0.00 |
| 91306 |
|
53 |
52 |
$0.00 |
| C1732 |
Catheter, electrophysiology, diagnostic/ablation, 3d or vector mapping |
13 |
13 |
$0.00 |
| 81370 |
|
13 |
12 |
$0.00 |
| 91303 |
|
40 |
39 |
$0.00 |
| J2543 |
Injection, piperacillin sodium/tazobactam sodium, 1 gram/0.125 grams (1.125 grams) |
23 |
12 |
$0.00 |
| G8987 |
Self care functional limitation, current status, at therapy episode outset and at reporting intervals |
17 |
15 |
$0.00 |
| G8980 |
Mobility: walking & moving around functional limitation, discharge status, at discharge from therapy or to end reporting |
12 |
12 |
$0.00 |
| 96139 |
|
12 |
12 |
$0.00 |
| 99396 |
Periodic comprehensive preventive medicine reevaluation, established patient, 40-64 years |
429 |
424 |
$0.00 |
| C1731 |
Catheter, electrophysiology, diagnostic, other than 3d mapping (20 or more electrodes) |
79 |
70 |
$0.00 |
| G8979 |
Mobility: walking & moving around functional limitation, projected goal status, at therapy episode outset, at reporting intervals, and at discharge or to end reporting |
241 |
223 |
$0.00 |
| G1004 |
Clinical decision support mechanism national decision support company, as defined by the medicare appropriate use criteria program |
2,764 |
2,070 |
$0.00 |
| 91311 |
|
68 |
64 |
$0.00 |
| J1956 |
Injection, levofloxacin, 250 mg |
172 |
157 |
$0.00 |
| 90836 |
|
204 |
144 |
$0.00 |
| 90833 |
Psychotherapy, 30 minutes with patient when performed with an E&M service (add-on) |
450 |
400 |
$0.00 |
| J0290 |
Injection, ampicillin sodium, 500 mg |
14 |
13 |
$0.00 |
| J1050 |
Injection, medroxyprogesterone acetate, 1 mg |
83 |
80 |
$0.00 |
| 91308 |
|
109 |
107 |
$0.00 |
| J1596 |
Injection, glycopyrrolate, 0.1 mg |
442 |
354 |
$0.00 |
| G8985 |
Carrying, moving and handling objects, projected goal status, at therapy episode outset, at reporting intervals, and at discharge or to end reporting |
177 |
162 |
$0.00 |
| J1580 |
Injection, garamycin, gentamicin, up to 80 mg |
178 |
158 |
$0.00 |
| J2916 |
Injection, sodium ferric gluconate complex in sucrose injection, 12.5 mg |
29 |
15 |
$0.00 |
| 90681 |
|
261 |
255 |
$0.00 |
| 76098 |
|
12 |
12 |
$0.00 |
| A4346 |
Indwelling catheter; foley type, three way for continuous irrigation, each |
201 |
172 |
$0.00 |
| J2919 |
Injection, methylprednisolone sodium succinate, 5 mg |
422 |
364 |
$0.00 |
| 91312 |
|
518 |
510 |
$0.00 |
| 90700 |
|
70 |
69 |
$0.00 |
| J0692 |
Injection, cefepime hydrochloride, 500 mg |
16 |
13 |
$0.00 |
| G8978 |
Mobility: walking & moving around functional limitation, current status, at therapy episode outset and at reporting intervals |
215 |
201 |
$0.00 |
| 90611 |
|
63 |
62 |
$0.00 |
| J0688 |
Injection, cefazolin sodium (hikma), not therapeutically equivalent to j0690, 500 mg |
521 |
484 |
$0.00 |
| G8984 |
Carrying, moving & handling objects functional limitation, current status, at therapy episode outset and at reporting intervals |
156 |
143 |
$0.00 |
| 90710 |
|
83 |
83 |
$0.00 |
| J2004 |
Injection, lidocaine hcl with epinephrine, 1 mg |
89 |
85 |
$0.00 |
| J2720 |
Injection, protamine sulfate, per 10 mg |
16 |
15 |
$0.00 |
| J2598 |
Injection, vasopressin, 1 unit |
112 |
103 |
$0.00 |
| 94690 |
|
13 |
13 |
$0.00 |
| G8990 |
Other physical or occupational therapy primary functional limitation, current status, at therapy episode outset and at reporting intervals |
13 |
12 |
$0.00 |
| J0136 |
Injection, acetaminophen (b braun), not therapeutically equivalent to j0131, 10 mg |
13 |
13 |
$0.00 |
| J2550 |
Injection, promethazine hcl, up to 50 mg |
19 |
16 |
$0.00 |
| 90838 |
|
21 |
13 |
$0.00 |
| 77387 |
|
71 |
12 |
$0.00 |